Difference between revisions of "Acute cystitis"

(Complicated)
(Elderly)
 
(8 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 
''This page is for adult patients; see [[urinary tract infection (peds)]] for pediatric patients.''
 
''This page is for adult patients; see [[urinary tract infection (peds)]] for pediatric patients.''
 
==Background==
 
==Background==
 +
[[File:2605 The Bladder.jpg|thumb|Anatomy of the bladder (male)]]
 
{{UTI types}}
 
{{UTI types}}
  
Line 21: Line 22:
 
*Neonatal  
 
*Neonatal  
 
*Comorbidities ([[DM]], [[sickle cell disease]])
 
*Comorbidities ([[DM]], [[sickle cell disease]])
*Pregnancy
+
*[[Pregnancy]]
 
*Immunosuppression ([[AIDS]], immunosuppressive drugs)
 
*Immunosuppression ([[AIDS]], immunosuppressive drugs)
 
*Advanced neurologic disease ([[CVA]] with disability, [[Spinal Cord Injuries]])
 
*Advanced neurologic disease ([[CVA]] with disability, [[Spinal Cord Injuries]])
Line 56: Line 57:
  
 
==Evaluation==
 
==Evaluation==
 +
[[File:Pyuria2011.jpg|thumb|Urine with pyuria.]]
 
===Urine Analysis (UA)===
 
===Urine Analysis (UA)===
 
====WBC count====
 
====WBC count====
 
*WBC >5 in patient with appropriate symptoms is diagnostic
 
*WBC >5 in patient with appropriate symptoms is diagnostic
 
**Lower degrees of pyuria may still be clinically significant in presence of symptoms
 
**Lower degrees of pyuria may still be clinically significant in presence of symptoms
***False negative may be due to: dilute urine, systemic leukopenia, obstruction
+
***False negative may be due to: dilute urine, systemic leukopenia, obstruction, recent antibiotic use with incomplete treatment
 
**WBC 1-2 with bacteriuria can be significant in men
 
**WBC 1-2 with bacteriuria can be significant in men
 
***More likely represents [[urethritis]] or [[prostatitis]] from [[STI]]
 
***More likely represents [[urethritis]] or [[prostatitis]] from [[STI]]
Line 90: Line 92:
 
*Consider local resistance patterns (if >10-20% use a different agent)
 
*Consider local resistance patterns (if >10-20% use a different agent)
 
*Avoid use of fluoroquinolones for uncomplicated cystitis if possible
 
*Avoid use of fluoroquinolones for uncomplicated cystitis if possible
*Consider [[phenazopyridine]] 100-200mg TID after meals x 2 days for pain control (bladder analgesic)
+
*Consider [[phenazopyridine]] for dysuria symptoms
 +
**100-200mg TID after meals x 2 days for pain control (bladder analgesic)
 +
**Warn of discoloration of urine and tears. Don’t wear contact lens due to risk of staining.<ref>Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.</ref>
  
 
;Complicated if:
 
;Complicated if:
Line 109: Line 113:
  
 
===Complicated===
 
===Complicated===
*Consider admittion for period of observation and/or culture results
+
*Consider admission for period of observation and/or culture results
  
 
==Special Populations==
 
==Special Populations==
Line 116: Line 120:
 
**[[Fluoroquinolones]] should be initial antibiotic of choice
 
**[[Fluoroquinolones]] should be initial antibiotic of choice
 
*Most acute cystitis is caused by typical pathogens or common [[STI]] organisms
 
*Most acute cystitis is caused by typical pathogens or common [[STI]] organisms
 +
 
===Pregnant Women===
 
===Pregnant Women===
 
*Treat all cases of asymptomatic bacteriuria
 
*Treat all cases of asymptomatic bacteriuria
 
==Pearls<ref>Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.</ref>==
 
*In female patients with dysuria, consider vaginitis (trichomoniasis, candidiasis) or urethritis (N. gonorrheae/Chlamydia)
 
*Elderly patients with pyelonephritis: 20% present with primary respiratory or GI symptoms. Also 33% are afebrile.
 
*[[Phenazopyridine]] for dysuria symptoms: Be sure to warn of discoloration of urine and tears. Don’t wear contact lens due to risk of staining.
 
  
 
==See Also==
 
==See Also==

Latest revision as of 09:35, 2 May 2020

This page is for adult patients; see urinary tract infection (peds) for pediatric patients.

Background

Anatomy of the bladder (male)

Genitourinary infection

(1) Human urinary system: (2) kidney; (3) renal pelvis; (4) ureter; (5) urinary bladder (6) urethra.
Additional structures: (7) adrenal gland; (8) renal artery and vein; (9) inferior vena cava; (10) abdominal aorta; (11) common iliac artery and vein; (12) liver; (13) large intestine; (14) pelvis.

"UTI" frequently refers specifically to acute cystitis, but may also be used as a general term for all urinary infections; use location-specific diagnosis.

Definitions

  • Relapse
    • Recurrence of symptoms within month despite treatment
      • Caused by same organism and represents treatment failure
  • Reinfection
    • Development of symptoms 1-6mo after treatment
    • Usually due to a different organism
    • If patient has >3 recurrences in 1 yr consider tumor, calculi, diabetes

Risk Factors

  • Anatomic abnormality of urinary tract or external drainage system
    • Indwelling urinary catheter, stent
    • Nephrolithiasis, neurogenic bladder, polycystic renal disease, recent instrumentation
  • Recurrent acute cystitis
  • Advanced age in men (BPH, recent instrumentation, recent prostatic biopsy)
  • Nursing home residency
  • Neonatal
  • Comorbidities (DM, sickle cell disease)
  • Pregnancy
  • Immunosuppression (AIDS, immunosuppressive drugs)
  • Advanced neurologic disease (CVA with disability, Spinal Cord Injuries)

Microbiology

Clinical Features

Uncomplicated

Complicated

Suspect pyelonephritis, infected kidney stone, or other disease process in patients who have inadequate or atypical response to treatment

Differential Diagnosis

Major

Pelvic Pain

Pelvic origin

Abdominal origin

Dysuria

Evaluation

Urine with pyuria.

Urine Analysis (UA)

WBC count

  • WBC >5 in patient with appropriate symptoms is diagnostic
    • Lower degrees of pyuria may still be clinically significant in presence of symptoms
      • False negative may be due to: dilute urine, systemic leukopenia, obstruction, recent antibiotic use with incomplete treatment
    • WBC 1-2 with bacteriuria can be significant in men
    • High WBCs w/o bacteria, consider TB, Chlamydia, Appendicitis

Leukocyte Esterase

  • Found in PMNs
  • High sensitivity
  • Low specificity

Nitrite

  • Very high specificity (>90%) in confirming diagnosis
  • Low sensitivity (enterococcus, pseudomonas, acinetobacter are not detected)

Urine Culture

  • Indicated for:
    • Complicated acute cystitis
    • Pyelonephritis
    • Pregnant women
    • Children
    • Adult males
    • Relapse/reinfection

Blood Culture

Management

  • Consider local resistance patterns (if >10-20% use a different agent)
  • Avoid use of fluoroquinolones for uncomplicated cystitis if possible
  • Consider phenazopyridine for dysuria symptoms
    • 100-200mg TID after meals x 2 days for pain control (bladder analgesic)
    • Warn of discoloration of urine and tears. Don’t wear contact lens due to risk of staining.[3]
Complicated if
  • Symptoms >7days
  • Diabetes mellitus
  • Urinary tract infection in previous 4wk
  • Men
  • >65 years old
  • Women who use spermicides or diaphragm
  • Relapse
  • Pregnancy

Outpatient

Women, Uncomplicated

  • Nitrofurantoin ER 100mg BID x 5d, OR
  • TMP/SMX DS (160/800mg) 1 tab BID x 3d, OR
  • Cephalexin 250mg QID x 5d, OR
  • Ciprofloxacin 250mg BID x3d
    • Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.[4]
  • Fosfomycin 3 g PO once
    • Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days [5]

Women, Complicated

Women, Concern for Urethritis

Men

Inpatient Options

Disposition

Uncomplicated

  • Admit for inability to tolerate PO

Complicated

  • Consider admission for period of observation and/or culture results

Special Populations

AIDS

  • TMP-SMX resistance is increased due to its use in PCP pneumonia prophylaxis
  • Most acute cystitis is caused by typical pathogens or common STI organisms

Pregnant Women

  • Treat all cases of asymptomatic bacteriuria

See Also

References

  1. Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
  2. Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
  3. Norris DL, Young JD. UTI. EM Clin N Am. 2008; 26:413-30.
  4. Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society
  5. Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.